116 related articles for article (PubMed ID: 9464659)
1. Bcl-2 and Bax proteins in Lewy bodies from patients with Parkinson's disease and Diffuse Lewy body disease.
Tortosa A; López E; Ferrer I
Neurosci Lett; 1997 Nov; 238(1-2):78-80. PubMed ID: 9464659
[TBL] [Abstract][Full Text] [Related]
2. Is Bax a mitochondrial mediator in apoptotic death of dopaminergic neurons in Parkinson's disease?
Hartmann A; Michel PP; Troadec JD; Mouatt-Prigent A; Faucheux BA; Ruberg M; Agid Y; Hirsch EC
J Neurochem; 2001 Mar; 76(6):1785-93. PubMed ID: 11259496
[TBL] [Abstract][Full Text] [Related]
3. Synaptophysin and chromogranin A immunoreactivities of Lewy bodies in Parkinson's disease brains.
Nishimura M; Tomimoto H; Suenaga T; Nakamura S; Namba Y; Ikeda K; Akiguchi I; Kimura J
Brain Res; 1994 Jan; 634(2):339-44. PubMed ID: 8131084
[TBL] [Abstract][Full Text] [Related]
4. Sequestration of iron by Lewy bodies in Parkinson's disease.
Castellani RJ; Siedlak SL; Perry G; Smith MA
Acta Neuropathol; 2000 Aug; 100(2):111-4. PubMed ID: 10963356
[TBL] [Abstract][Full Text] [Related]
5. Cell death and apoptosis regulating proteins in Parkinson's disease--a cautionary note.
Wüllner U; Kornhuber J; Weller M; Schulz JB; Löschmann PA; Riederer P; Klockgether T
Acta Neuropathol; 1999 Apr; 97(4):408-12. PubMed ID: 10208281
[TBL] [Abstract][Full Text] [Related]
6. BAX protein-immunoreactivity in midbrain neurons of Parkinson's disease patients.
Horowitz JM; Pastor DM; Goyal A; Kar S; Ramdeen N; Hallas BH; Torres G
Brain Res Bull; 2003 Nov; 62(1):55-61. PubMed ID: 14596892
[TBL] [Abstract][Full Text] [Related]
7. Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies.
Spillantini MG; Crowther RA; Jakes R; Cairns NJ; Lantos PL; Goedert M
Neurosci Lett; 1998 Jul; 251(3):205-8. PubMed ID: 9726379
[TBL] [Abstract][Full Text] [Related]
8. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.
Baba M; Nakajo S; Tu PH; Tomita T; Nakaya K; Lee VM; Trojanowski JQ; Iwatsubo T
Am J Pathol; 1998 Apr; 152(4):879-84. PubMed ID: 9546347
[TBL] [Abstract][Full Text] [Related]
9. 14-3-3 proteins in Lewy bodies in Parkinson disease and diffuse Lewy body disease brains.
Kawamoto Y; Akiguchi I; Nakamura S; Honjyo Y; Shibasaki H; Budka H
J Neuropathol Exp Neurol; 2002 Mar; 61(3):245-53. PubMed ID: 11895039
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical localization of X-linked inhibitor of apoptosis protein in brainstem-type and cortical Lewy bodies.
Kawamoto Y; Ito H; Ihara M; Takahashi R
Neuroreport; 2012 Feb; 23(3):162-7. PubMed ID: 22273571
[TBL] [Abstract][Full Text] [Related]
11. Colocalization of tau and alpha-synuclein epitopes in Lewy bodies.
Ishizawa T; Mattila P; Davies P; Wang D; Dickson DW
J Neuropathol Exp Neurol; 2003 Apr; 62(4):389-97. PubMed ID: 12722831
[TBL] [Abstract][Full Text] [Related]
12. Filaments of Lewy bodies contain insoluble cytoskeletal elements.
Galloway PG; Mulvihill P; Perry G
Am J Pathol; 1992 Apr; 140(4):809-22. PubMed ID: 1314025
[TBL] [Abstract][Full Text] [Related]
13. What causes the build-up of ubiquitin-containing inclusions in Parkinson's disease?
Andersen JK
Mech Ageing Dev; 2000 Sep; 118(1-2):15-22. PubMed ID: 10989121
[TBL] [Abstract][Full Text] [Related]
14. PLA2G6 accumulates in Lewy bodies in PARK14 and idiopathic Parkinson's disease.
Miki Y; Tanji K; Mori F; Kakita A; Takahashi H; Wakabayashi K
Neurosci Lett; 2017 Apr; 645():40-45. PubMed ID: 28213071
[TBL] [Abstract][Full Text] [Related]
15. Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity.
Irizarry MC; Growdon W; Gomez-Isla T; Newell K; George JM; Clayton DF; Hyman BT
J Neuropathol Exp Neurol; 1998 Apr; 57(4):334-7. PubMed ID: 9600226
[TBL] [Abstract][Full Text] [Related]
16. Lewy bodies: purification from diffuse Lewy body disease brains.
Iwatsubo T; Yamaguchi H; Fujimuro M; Yokosawa H; Ihara Y; Trojanowski JQ; Lee VM
Ann N Y Acad Sci; 1996 Jun; 786():195-205. PubMed ID: 8687019
[No Abstract] [Full Text] [Related]
17. Bcl-2 and Bax protein expression in neurofibrillary tangles in progressive supranuclear palsy.
Tortosa A; Blanco R; Ferrer I
Neuroreport; 1998 Apr; 9(6):1049-52. PubMed ID: 9601665
[TBL] [Abstract][Full Text] [Related]
18. Purification and characterization of Lewy bodies from the brains of patients with diffuse Lewy body disease.
Iwatsubo T; Yamaguchi H; Fujimuro M; Yokosawa H; Ihara Y; Trojanowski JQ; Lee VM
Am J Pathol; 1996 May; 148(5):1517-29. PubMed ID: 8623921
[TBL] [Abstract][Full Text] [Related]
19. Microtubule-associated protein 5 is a component of Lewy bodies and Lewy neurites in the brainstem and forebrain regions affected in Parkinson's disease.
Gai WP; Blumbergs PC; Blessing WW
Acta Neuropathol; 1996; 91(1):78-81. PubMed ID: 8773150
[TBL] [Abstract][Full Text] [Related]
20. TorsinA accumulation in Lewy bodies in sporadic Parkinson's disease.
Shashidharan P; Good PF; Hsu A; Perl DP; Brin MF; Olanow CW
Brain Res; 2000 Sep; 877(2):379-81. PubMed ID: 10986355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
